SLC5A2 and heart failure: Although the exact mechanism by which SGLT-2 inhibitors help reduce mortality and morbidity among heart failure patients remains elusive, results reported by many clinical trials established the clear cardiovascular benefits when SGLT-2 inhibitors are used among heart failure patients [18,19].